COMPOSITION FOR DECREASING INFLAMMATION MARKER COMPRISING PHOSPHATIDYLCHOLINE

摘要

Disclosed are a pharmaceutical product for oral administration or for oral cavity application, a functional food and an oral composition which can prevent or ameliorate a disorder in the physical function induced by the increase in an inflammation marker, which can reduce the occurrence of metabolic syndrome or the risk of a disease and metabolic syndrome, and which can maintain or promote the healthy state. Disclosed is a phosphatidylcholine derived from soybean, preferably a phosphatidylcholine having an unsaturated fatty acid (particularly linoleic acid or linolenic acid) bound to at least one of position-1 and position-2. The phosphatidylcholine can be used in a capsule, a tablet or a liquid preparation. The phosphatidylcholine is preferably used in the form of a liposome. A liposome or lipid microsphere comprising the phosphatidylcholine may include a ?3 unsaturated fatty acid therein.